Hermetica Superfood Encyclopedia
The Short Answer
Cassia alata contains anthraquinones (alatinone, alatonal, chrysarobin, emodin, aloe-emodin) and flavonoids (kaempferol, quercetin derivatives) that disrupt fungal cell membranes, inhibit microbial enzyme systems, and scavenge free radicals through hydroxyl-group-mediated metal chelation. In vitro studies document antifungal activity against dermatophytes and antibacterial zones of inhibition of 9.7–14.8 mm against E. coli and S. aureus, while isolated aloe-emodin and emodin show cytotoxicity against MCF-7 breast cancer cells at IC50 values of 12.7 ppm and 18.1 ppm respectively.
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary Keywordcassia alata benefits
Candlestick Bush — botanical close-up
Health Benefits
**Antifungal / Antidermatophytic Activity**
Anthraquinones alatinone and alatonal, alongside chrysarobin, disrupt fungal cell wall integrity and membrane function; the plant's traditional use against ringworm (tinea) is corroborated by in vitro inhibition of dermatophytic fungi, supporting its widespread folk dermatological application.
**Antibacterial Action**
Fatty acid constituents (linoleic acid, palmitic acid, stearic acid) alongside flavonoid and anthraquinone glycosides produced zones of inhibition of 9.7–14.8 mm against both gram-positive Staphylococcus aureus and gram-negative Escherichia coli in disk-diffusion assays, suggesting broad-spectrum bacteriostatic potential.
**Antioxidant Protection**
The proanthocyanidin tetramer and phenolic compounds including epigallocatechin gallate, kaempferol, and ferulic acid scavenge DPPH and ABTS free radicals and chelate redox-active metal ions, reducing oxidative stress; this activity has been demonstrated to arrest mitochondrial oxidative stress in HT-115 colon cancer cells in vitro.
**Anti-inflammatory Effects**
Leaf extracts suppress LPS-induced TNF-α production in a dose-dependent manner, with 1 mg of extract providing the most effective inhibition, attributable to chrysarobin, chrysophanol glycosides, kaempferol, and tannins modulating pro-inflammatory cytokine cascades.
**Antidiabetic Potential**: Emodin and related compounds from C
alata flowers inhibit α-glucosidase (IC50 = 0.85 mg/mL) and α-amylase (IC50 = 6.41 mg/mL) in vitro, mechanistically slowing postprandial glucose absorption; an in silico study by Thilak et al. (2023) identified five additional compounds with predicted antidiabetic binding activity.
**Anticancer Cytotoxicity**: Isolated aloe-emodin (IC50 = 12
7 ppm), emodin (IC50 = 18.1 ppm), and kaempferol (IC50 = 131.3 ppm) exhibited cytotoxic activity against MCF-7 human breast cancer cells in vitro, while whole ethanolic leaf extract demonstrated activity at IC50 < 100 µg/mL without measurable toxicity to normal cell lines.
**Skin Disease Management**
The combination of antifungal anthraquinones, anti-inflammatory flavonoids, and antimicrobial fatty acids creates a multimodal topical action that has supported centuries of traditional use in treating scabies, eczema, ringworm, and other dermatological conditions across Southeast Asian and African folk medicine systems.
Origin & History
Natural habitat
Cassia alata L. (also classified as Senna alata) is native to tropical regions of Central and South America and has naturalized extensively across Southeast Asia, Africa, and the Pacific Islands, thriving in disturbed soils, roadsides, and forest margins at low to mid elevations. It grows as a fast-maturing perennial shrub reaching 3–4 meters, favoring humid, sunny environments with well-drained lateritic or clay soils typical of the Philippine, Indonesian, and Malaysian lowlands. Traditional cultivation is informal and largely wild-harvested, with leaves gathered year-round and used fresh or dried in folk medicine preparations across Thailand, the Philippines, Nigeria, and Malaysia.
“Cassia alata has a well-documented ethnomedicinal history spanning Southeast Asia (Philippines, Indonesia, Thailand, Malaysia), West Africa (Nigeria, Ghana), the Caribbean, and Latin America, where it earned vernacular names including 'akapulko' in the Philippines, 'gelenggang' in Malaysia, 'ringworm bush' in the Caribbean, and 'candelabra bush' in Nigeria, each name reflecting its prominent folk use against fungal skin infections. In the Philippines, akapulko leaf preparations are one of the ten medicinal plants formally endorsed by the Philippine Department of Health under the Traditional Medicine program, making it one of the few Southeast Asian botanicals with semi-official governmental recognition for topical antifungal use. Traditional healers across West Africa prepared leaf pastes for treatment of ringworm, tinea versicolor, and scabies, while the plant's cathartic anthraquinones were also exploited in laxative preparations throughout tropical Asia and Africa. The plant features in Ayurvedic-adjacent and Unani compilations under related Senna genus classifications and appears in colonial-era botanical records from the Philippines dating to the late 19th century, underscoring a multi-century cross-cultural medicinal tradition.”Traditional Medicine
Scientific Research
The existing evidence base for Cassia alata is composed almost entirely of in vitro cell culture studies and in silico computational modeling experiments, with no published human clinical trials documenting efficacy, safety, or pharmacokinetic parameters. Key laboratory investigations include Khoerunisah et al. (2022), demonstrating cytotoxicity of isolated anthraquinones against MCF-7 breast cancer cells; Chahardehi et al. (2020), reporting whole ethanolic leaf extract anticancer activity (IC50 < 100 µg/mL) with preserved normal cell viability; and Thilak et al. (2023), an in silico molecular docking study identifying five C. alata compounds with predicted antidiabetic target binding. Antimicrobial data derive from disk-diffusion assays showing 9.7–14.8 mm inhibition zones against E. coli and S. aureus, and phytochemical profiling has catalogued 88 compounds, 32 with documented bioactivity; however, the translation of these findings to human therapeutic benefit remains unestablished without controlled clinical research.
Preparation & Dosage
Traditional preparation
**Fresh Leaf Poultice (Traditional Topical)**
Leaves are crushed or ground into a paste and applied directly to affected skin areas (ringworm, scabies, eczema) once or twice daily; no standardized dose established, duration typically 7–14 days in folk practice.
**Leaf Decoction (Traditional Oral/Topical Wash)**
30–50 g of fresh leaves boiled in 500 mL water for 15–20 minutes; used as a topical rinse for skin infections or consumed orally for laxative effects in traditional systems
Approximately .
**Methanolic/Ethanolic Extract (Laboratory Research Form)**
Extracts prepared at concentrations of 100–1000 µg/mL for in vitro bioassay; no human-equivalent dose established from these concentrations.
**Standardized Extract (Preclinical Reference)**
No commercial standardization to anthraquinone or flavonoid content has been formally validated; research fractions reference total phenolics of 6.67–7.65% GAE/g and total flavonoids of 9.86–15.74% QE/g as phytochemical benchmarks.
**Dosage Note**
No safe or effective human supplemental dose has been established for any form of Cassia alata; all dosage references in the literature are for laboratory extract concentrations and cannot be directly translated to human use without clinical validation.
Nutritional Profile
Cassia alata leaves contain a rich phytochemical matrix of 88 identified compounds rather than a conventional macronutrient-dominant profile. Total phenolic content measures 6.67–7.65% GAE/g (gallic acid equivalents per gram) and total flavonoids 9.86–15.74% QE/g (quercetin equivalents per gram) in dried leaf material. Key anthraquinones include alatinone, alatonal, chrysarobin, emodin, aloe-emodin, and chrysophanol, while flavonoids encompass kaempferol, kaempferol-3,7-diglucoside, quercetin-3-rhamnoside-7-glucoside, marimetin, agathisflavone, and amentoflavone. Phenolic acids present include caffeic acid, ferulic acid, o-coumaric acid, epigallocatechin gallate, and anacardic acid triene; fatty acid components include linoleic acid, palmitic acid, stearic acid, oleic acid, and neophytadiene. Alkaloids, tannins, saponins, terpenoids, steroids, and volatile oils complete the phytochemical inventory; bioavailability of anthraquinones and flavonoids in humans is influenced by gut microbiota metabolism, food matrix effects, and extraction solvent polarity, none of which have been formally studied for this species.
How It Works
Mechanism of Action
The antifungal activity of Cassia alata is primarily mediated by anthraquinones—alatinone, alatonal, chrysarobin, emodin, and aloe-emodin—which intercalate into fungal DNA, generate reactive oxygen species within pathogen cells, and compromise membrane lipid bilayer integrity, collectively inhibiting fungal replication and inducing cell death in dermatophytes. Anti-inflammatory effects are achieved through suppression of nuclear factor-kappa B (NF-κB)-dependent cytokine transcription; chrysophanol glycosides and kaempferol attenuate LPS-triggered TLR4 signaling, reducing downstream TNF-α and interleukin production. Antioxidant mechanisms involve phenolic hydroxyl groups donating hydrogen atoms to neutralize DPPH and ABTS radicals and chelating ferrous and cupric ions through ortho-dihydroxy motifs, thereby interrupting Fenton-type radical chain reactions and protecting mitochondrial respiratory complexes. The antidiabetic mechanism centers on competitive enzyme inhibition: emodin and related quinone derivatives occupy the active sites of α-glucosidase (IC50 = 0.85 mg/mL) and α-amylase (IC50 = 6.41 mg/mL), slowing intestinal carbohydrate hydrolysis and blunting postprandial glycemic excursions.
Clinical Evidence
There are currently no published human clinical trials—randomized controlled or otherwise—evaluating Cassia alata for any therapeutic indication, meaning no clinical effect sizes, confidence intervals, or human pharmacokinetic data exist to draw upon. All reported quantitative outcomes originate from in vitro assays (IC50 values, zones of inhibition, DPPH radical scavenging percentages) and one in silico docking study, which cannot be extrapolated directly to human therapeutic doses or clinical outcomes. Traditional use across Southeast Asia, West Africa, and Latin America provides ethnopharmacological plausibility for topical antifungal and anti-inflammatory applications, but this evidence is entirely observational and lacks methodological controls. The overall confidence in clinical benefit is therefore low; the ingredient is best characterized as a promising preclinical candidate warranting rigorously designed phase I safety and exploratory efficacy trials in humans.
Safety & Interactions
Formal human safety studies for Cassia alata are absent from the published literature; the available preclinical safety signals are limited to brine shrimp lethality testing (LC50 > 1000 µg/mL, classified as non-toxic) and in vitro cytotoxicity assays showing that ethanolic leaf extract did not harm normal cell lines at anticancer-active concentrations. The plant's significant anthraquinone content (emodin, aloe-emodin, chrysarobin) raises theoretical concerns about laxative and potentially mutagenic effects with chronic oral consumption at high doses, consistent with known anthraquinone-class safety considerations documented for related Senna species. Potential interactions with antidiabetic medications (additive α-glucosidase inhibition), laxatives, and immunosuppressive drugs should be considered due to overlapping mechanistic activity, though no human pharmacodynamic interaction studies have been conducted. Use during pregnancy and lactation is not recommended given the cathartic anthraquinone content and the complete absence of safety data in these populations; individuals with inflammatory bowel disease or renal dysfunction should exercise particular caution.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Cassia alata L.Senna alataAkapulkoRingworm BushCandle BushGelenggangCandelabra BushEmperor's Candlesticks
Frequently Asked Questions
What is Cassia alata used for traditionally?
Cassia alata has been used across Southeast Asia, West Africa, and Latin America primarily as a topical remedy for fungal skin conditions including ringworm (tinea), scabies, eczema, and tinea versicolor, with leaves crushed into paste and applied directly to affected areas. In the Philippines, where it is called 'akapulko,' it is one of ten plants officially recognized by the Department of Health for traditional medicinal use. Its cathartic anthraquinone content has also led to traditional oral use as a laxative in several cultures.
Does Cassia alata really kill ringworm and fungal infections?
In vitro laboratory studies demonstrate that anthraquinone compounds in Cassia alata—particularly alatinone, alatonal, chrysarobin, and emodin—disrupt fungal cell membrane integrity and inhibit dermatophyte growth, providing a plausible biochemical basis for its traditional antifungal use. However, no controlled human clinical trials have confirmed this activity in people, and the effective concentration in laboratory assays cannot be directly translated to dosing guidelines for topical preparations. The folk use is centuries-old and ethnopharmacologically plausible, but clinical validation remains a research gap.
Is Cassia alata safe to use on skin or take internally?
Topical application of Cassia alata leaf preparations appears to have a reasonable folk safety record, and in vitro brine shrimp lethality testing (LC50 > 1000 µg/mL) classified plant extracts as non-toxic at preclinical level. Internal (oral) use raises greater concern because the plant contains emodin, aloe-emodin, and chrysarobin—anthraquinones that can act as stimulant laxatives and have been flagged for potential mutagenicity with long-term high-dose consumption in related Senna species. No formal human safety trials exist, so internal use should be approached with caution, and it is not recommended during pregnancy or breastfeeding.
What are the active compounds in Cassia alata?
Cassia alata contains 88 identified phytochemicals, with the most pharmacologically significant being anthraquinones (alatinone, alatonal, chrysarobin, emodin, aloe-emodin, chrysophanol) responsible for antifungal and laxative effects, and flavonoids (kaempferol, kaempferol-3,7-diglucoside, quercetin-3-rhamnoside-7-glucoside, marimetin) responsible for antioxidant and anti-inflammatory activity. Total phenolic content measures 6.67–7.65% GAE/g and total flavonoids 9.86–15.74% QE/g in dried leaf material. Additional components include caffeic acid, ferulic acid, epigallocatechin gallate, linoleic acid, palmitic acid, saponins, tannins, and alkaloids.
How do you prepare Cassia alata leaf for skin conditions?
The most common traditional preparation involves crushing or grinding fresh Cassia alata leaves into a paste using a mortar and pestle, then applying this directly to affected skin areas such as ringworm patches once or twice daily for 7–14 days. A decoction method uses approximately 30–50 g of fresh leaves simmered in 500 mL of water for 15–20 minutes to produce a wash used topically on infected skin. No standardized commercial preparation currently exists, and no clinical trials have validated an optimal preparation method or treatment duration.
Is Cassia alata safe to use during pregnancy or while breastfeeding?
There is limited clinical safety data for Cassia alata use during pregnancy and breastfeeding, so it is generally recommended to avoid internal use during these periods as a precaution. Topical application to small skin areas may carry lower risk, but pregnant and nursing women should consult a healthcare provider before use due to the plant's potent anthraquinone content and potential systemic absorption. The traditional safety profile does not eliminate the need for caution in vulnerable populations.
How does Cassia alata compare to conventional antifungal medications like tolnaftate or terbinafine?
Cassia alata contains active compounds (alatinone, alatonal, and chrysarobin) that inhibit dermatophytic fungi in vitro, but clinical efficacy trials comparing it directly to prescription antifungals like terbinafine are limited. While traditional use and preliminary studies support its antifungal potential, conventional medications have more extensive clinical evidence for consistent cure rates and standardized dosing. For severe or systemic fungal infections, prescription antifungals remain the evidence-based first-line treatment, though Cassia alata may serve as a complementary option for mild topical cases.
What is the evidence quality for Cassia alata's effectiveness against different types of fungal infections?
Most evidence for Cassia alata is derived from in vitro studies and ethnopharmacological data showing inhibition of common dermatophytes (Trichophyton, Microsporum, and Epidermophyton species), rather than large-scale clinical trials in humans. A few small-scale clinical studies support efficacy against ringworm and other tinea infections, but sample sizes are typically modest and methodology varies widely. Stronger clinical research with standardized preparations and larger participant populations would be needed to establish definitive efficacy benchmarks compared to other treatments.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w candlestick-bush-cassia-alata-l curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
